Movement Alert｜Medline Falls 3.71% in Regular Trading, FDA Violation Probe and Shareholder Selling Continue to Pressure Stock

Market Focus07-15

On July 14, Medline Inc fell 3.71% in regular trading, trading at $39.075/share, with turnover of $116 million, extending its recent downtrend.

The decline is driven by sustained regulatory headwinds. The FDA issued two warning letters within two months citing serious violations of current good manufacturing practice (CGMP) regulations at the company's Illinois facility. Medline is required to submit a corrective action plan within 15 business days or face potential suspension of export certificates and further enforcement. The company also faces a securities fraud investigation tied to the regulatory issues.

Adding to the selling pressure, stockholders affiliated with Blackstone, Carlyle, Hellman & Friedman, and the Abu Dhabi Investment Authority have conducted multiple rounds of large-scale secondary offerings since March, including a 75-million-share offering priced at $41 and a subsequent upsized 72.6-million-share offering at $37. The Healthcare Supplies sector traded broadly lower on the same day, with peers including ICU Medical down 3.92%, Cooper down 2.93%, UFP Technologies down 2.93%, Alcon down 2.78%, and Align Technology down 1.56%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1108676978?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 00:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108676978","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Medline Falls 3.71% in Regular Trading, FDA Violation Probe and Shareholder Selling Continue to Pressure Stock","media":"Market Focus","content":"<p><p>On July 14, Medline Inc fell 3.71% in regular trading, trading at $39.075/share, with turnover of $116 million, extending its recent downtrend.</p><p>The decline is driven by sustained regulatory headwinds. The FDA issued two warning letters within two months citing serious violations of current good manufacturing practice (CGMP) regulations at the company's Illinois facility. Medline is required to submit a corrective action plan within 15 business days or face potential suspension of export certificates and further enforcement. The company also faces a securities fraud investigation tied to the regulatory issues.</p><p>Adding to the selling pressure, stockholders affiliated with Blackstone, Carlyle, Hellman & Friedman, and the Abu Dhabi Investment Authority have conducted multiple rounds of large-scale secondary offerings since March, including a 75-million-share offering priced at $41 and a subsequent upsized 72.6-million-share offering at $37. The Healthcare Supplies sector traded broadly lower on the same day, with peers including ICU Medical down 3.92%, Cooper down 2.93%, UFP Technologies down 2.93%, Alcon down 2.78%, and Align Technology down 1.56%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Medline Falls 3.71% in Regular Trading, FDA Violation Probe and Shareholder Selling Continue to Pressure Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Medline Falls 3.71% in Regular Trading, FDA Violation Probe and Shareholder Selling Continue to Pressure Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-15 00:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 14, Medline Inc fell 3.71% in regular trading, trading at $39.075/share, with turnover of $116 million, extending its recent downtrend.</p><p>The decline is driven by sustained regulatory headwinds. The FDA issued two warning letters within two months citing serious violations of current good manufacturing practice (CGMP) regulations at the company's Illinois facility. Medline is required to submit a corrective action plan within 15 business days or face potential suspension of export certificates and further enforcement. The company also faces a securities fraud investigation tied to the regulatory issues.</p><p>Adding to the selling pressure, stockholders affiliated with Blackstone, Carlyle, Hellman & Friedman, and the Abu Dhabi Investment Authority have conducted multiple rounds of large-scale secondary offerings since March, including a 75-million-share offering priced at $41 and a subsequent upsized 72.6-million-share offering at $37. The Healthcare Supplies sector traded broadly lower on the same day, with peers including ICU Medical down 3.92%, Cooper down 2.93%, UFP Technologies down 2.93%, Alcon down 2.78%, and Align Technology down 1.56%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDLN","symbol_name":"Medline Inc","start_time":0,"source_url":"","article_id":"1108676978","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108676978","pubTimestamp":1784045712,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 14, Medline Inc fell 3.71% in regular trading, trading at $39.075/share, with turnover of $116 million, extending its recent downtrend.The decline is driven by sustained regulatory headwinds....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDLN":"Medline Inc"},"translate_title":"走势警报|Medline 常规交易中下跌 3.71%，FDA 违规调查和股东抛售继续给股价带来压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDLN":1},"content_text":"On July 14, Medline Inc fell 3.71% in regular trading, trading at $39.075/share, with turnover of $116 million, extending its recent downtrend.The decline is driven by sustained regulatory headwinds. The FDA issued two warning letters within two months citing serious violations of current good manufacturing practice (CGMP) regulations at the company's Illinois facility. Medline is required to submit a corrective action plan within 15 business days or face potential suspension of export certificates and further enforcement. The company also faces a securities fraud investigation tied to the regulatory issues.Adding to the selling pressure, stockholders affiliated with Blackstone, Carlyle, Hellman & Friedman, and the Abu Dhabi Investment Authority have conducted multiple rounds of large-scale secondary offerings since March, including a 75-million-share offering priced at $41 and a subsequent upsized 72.6-million-share offering at $37. The Healthcare Supplies sector traded broadly lower on the same day, with peers including ICU Medical down 3.92%, Cooper down 2.93%, UFP Technologies down 2.93%, Alcon down 2.78%, and Align Technology down 1.56%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1108676978","isCrawlerRequest":true}